好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Riluzole-induced interstitial pneumonia: a rare and potentially life-threatening adverse event successfully treated with high-dose steroids.
General Neurology
P2 - (-)
214
Authors/Disclosures
Yuji Saitoh, MD, FAAN (Tokyo Metropolitan Neurological Hospital)
PRESENTER
Dr. Saitoh has received stock or an ownership interest from Meiji Holdings Co. Ltd.. Dr. Saitoh has received stock or an ownership interest from Daiichi Sankyo Co. Ltd.. Dr. Saitoh has received stock or an ownership interest from Japan Tobacco Inc.. Dr. Saitoh has received stock or an ownership interest from Otsuka Holdings Co., Ltd.. Dr. Saitoh has received stock or an ownership interest from Fujifilm Holdings Corporation. Dr. Saitoh has received stock or an ownership interest from Johnson & Johnson. Dr. Saitoh has received stock or an ownership interest from 3M Company. The institution of Dr. Saitoh has received research support from Japan Agency for Medical Research and Development (AMED). Dr. Saitoh has received publishing royalties from a publication relating to health care. Dr. Saitoh has received publishing royalties from a publication relating to health care. Dr. Saitoh has received publishing royalties from a publication relating to health care.
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Madoka Mori-Yoshimura, MD, PhD (National Center Hospital, National Center of Neurology and Psychiatry) Dr. Mori-Yoshimura has nothing to disclose.
Toshiyuki Yamamoto (National Center Hospital, National Center of Neurology and Psychiatry) Dr. Yamamoto has nothing to disclose.
Tomoko Okamoto Tomoko Okamoto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Tomoko Okamoto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharma G.K.. Tomoko Okamoto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Tomoko Okamoto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Chugai Pharmaceutical Co., Ltd.. Tomoko Okamoto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teijin Pharma Limited.. The institution of Tomoko Okamoto has received research support from Alexion Pharma G.K.. The institution of Tomoko Okamoto has received research support from Sanofi. The institution of Tomoko Okamoto has received research support from Novartis. The institution of Tomoko Okamoto has received research support from UCB Japan Co., Ltd. The institution of Tomoko Okamoto has received research support from Biogen Japan Ltd.. The institution of Tomoko Okamoto has received research support from Chugai Pharmaceutical Co., Ltd.. The institution of Tomoko Okamoto has received research support from Mitsubishi Tanabe Pharma Corporation. Tomoko Okamoto has received intellectual property interests from a discovery or technology relating to health care.
Miho Murata No disclosure on file
Yuji Takahashi, MD, PhD (National Center of Neurology and Psychiatry) The institution of Dr. Takahashi has received research support from Nihon Medi-Physics Co. Limit.. The institution of Dr. Takahashi has received research support from Takeda Pharmaceutical Company Limited.